CSPC Pharmaceutical Group Limited (CSPCY)

USD 3.05

(-2.71%)

Long Term Debt Summary of CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical Group Limited's latest annual long term debt in 2023 was 107.05 Million CNY , down -62.7% from previous year.
CSPC Pharmaceutical Group Limited's latest quarterly long term debt in 2023 FY was 107.05 Million CNY , down -62.7% from previous quarter.
CSPC Pharmaceutical Group Limited reported annual long term debt of 286.98 Million CNY in 2022, up 415.98% from previous year.
CSPC Pharmaceutical Group Limited reported annual long term debt of 55.62 Million CNY in 2021, down -40.12% from previous year.
CSPC Pharmaceutical Group Limited reported quarterly long term debt of - CNY for 2023 Q1, down -100.0% from previous quarter.
CSPC Pharmaceutical Group Limited reported quarterly long term debt of 206.78 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of CSPC Pharmaceutical Group Limited (2023 - 2003)

Historical Annual Long Term Debt of CSPC Pharmaceutical Group Limited (2023 - 2003)

Year	Long Term Debt	Long Term Debt Growth
2023	107.05 Million CNY	-62.7%
2022	286.98 Million CNY	415.98%
2021	55.62 Million CNY	-40.12%
2020	92.87 Million CNY	2.86%
2019	90.3 Million CNY	0.0%
2018	- HKD	0.0%
2017	- HKD	0.0%
2016	- HKD	0.0%
2015	- HKD	0.0%
2014	- HKD	0.0%
2013	- HKD	0.0%
2012	- HKD	-100.0%
2011	49.95 Million HKD	0.36%
2010	49.77 Million HKD	0.0%
2009	- HKD	0.0%
2008	- HKD	0.0%
2007	- HKD	0.0%
2006	- HKD	0.0%
2005	- HKD	0.0%
2004	- HKD	0.0%
2003	- HKD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2023 FY	107.05 Million CNY	-62.7%
2023 Q1	- CNY	-100.0%
2023 Q2	206.78 Million CNY	0.0%
2023 Q3	- CNY	-100.0%
2023 Q4	107.05 Million CNY	0.0%
2022 Q2	205.44 Million CNY	0.0%
2022 Q4	286.98 Million CNY	0.0%
2022 FY	286.98 Million CNY	415.98%
2021 Q4	55.62 Million CNY	0.0%
2021 FY	55.62 Million CNY	-40.12%
2021 Q2	59.5 Million CNY	0.0%
2020 FY	92.87 Million CNY	2.86%
2020 Q2	108.57 Million CNY	0.0%
2020 Q4	92.87 Million CNY	0.0%
2019 Q2	126.63 Million CNY	0.0%
2019 FY	90.3 Million CNY	0.0%
2019 Q4	90.3 Million CNY	0.0%
2018 Q2	- HKD	0.0%
2018 FY	- HKD	0.0%
2018 Q4	- HKD	0.0%
2017 Q4	- HKD	0.0%
2017 Q2	- HKD	0.0%
2017 FY	- HKD	0.0%
2016 FY	- HKD	0.0%
2016 Q2	- HKD	0.0%
2016 Q4	- HKD	0.0%
2015 Q4	- HKD	0.0%
2015 Q2	- HKD	0.0%
2015 FY	- HKD	0.0%
2014 FY	- HKD	0.0%
2014 Q4	- HKD	0.0%
2014 Q2	- HKD	0.0%
2013 Q2	- HKD	0.0%
2013 Q4	- HKD	0.0%
2013 FY	- HKD	0.0%
2012 FY	- HKD	-100.0%
2012 Q4	- HKD	0.0%
2012 Q2	- HKD	0.0%
2011 FY	49.95 Million HKD	0.36%
2011 Q2	- HKD	0.0%
2011 Q4	49.95 Million HKD	0.0%
2010 Q4	49.77 Million HKD	0.0%
2010 FY	49.77 Million HKD	0.0%
2010 Q2	- HKD	0.0%
2009 Q4	- HKD	0.0%
2009 FY	- HKD	0.0%
2008 FY	- HKD	0.0%
2007 FY	- HKD	0.0%
2006 FY	- HKD	0.0%
2005 FY	- HKD	0.0%
2004 FY	- HKD	0.0%
2003 FY	- HKD	0.0%

Peer Long Term Debt Comparison of CSPC Pharmaceutical Group Limited

Name	Long Term Debt	Long Term Debt Difference
AstraZeneca PLC	22.33 Billion USD	99.521%
Bristol-Myers Squibb Company PFD CONV 2	38.18 Billion USD	99.72%
CSPC Pharmaceutical Group Limited	107.05 Million USD	0.0%
Clarus Therapeutics Holdings, Inc.	- USD	-Infinity%
Novartis AG	20.03 Billion USD	99.466%
PT Kalbe Farma Tbk.	19.39 Million USD	-452.076%